rendering of a globe and news stories

PPD in the News

Fierce Biotech (June 2020)

PPD expands lab test work to boost pandemic vaccine, drug trial research

PPD® Laboratories has developed five new molecular, serology and functional assays designed expressly for COVID-19 vaccine and therapy development programs.

Fierce Biotech
Pharmaceutical Outsourcing (June 2020)

Data review for today and the next generation

Robert King, Hunter Everton and Philip Bartle discuss how to tackle data reporting challenges while significantly reducing both time and cost.

pharmaceutical outsourcing logo
Contract Pharma (June 2020)

CAR-T Cell Therapy in Clinical Trials

Panteli Theocharous discusses the three major themes that have emerged in 2020 in response to the sharpened focus on advancing the development of CAR-T therapies.

contract pharma logo
BioPharm International (May 2020)

The limits of light obscuration

Brent Denton, John Bak and Jonathon Salsbury discuss how light obscuration testing is the preferred method of sub-visible particle quantification, but is not suitable for every preparation.

biopharm logo
Fierce Biotech (April 2020)

PPD boosts digital trial work amid pandemic

PPD is extending its digital clinical trial offering to support its biopharma clients' R&D as life science companies continue to find workarounds on trial delays.

fierce biotech logo
Fierce Biotech (April 2020)

PPD unit launches patient-transfer trial program to help ease pandemic cancellations

Accelerated Enrollment Solutions has introduced a new program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemic.

fierce biotech logo
Fierce Biotech (April 2020)

PPD unit pens Science 37 virtual trial pact amid pandemic

Accelerated Enrollment Solutions and Science 37 are collaborating to recruit and enroll clinical trial participants who live beyond the geographic location of traditional research sites.

fierce biotech logo
Regulatory Rapporteur (April 2020)

The expanding role of real-world evidence in the regulatory environment

Mel Formica, global head, value and development consulting, Evidera, discusses the challenges regulators face as they seek to understand the acceptability of cutting-edge real-world data.

regulatory rapporteur logo
American Pharmaceutical Review (March 2020)

Understanding the relationship between the red and blue light sources in the determination of particle size distribution profiles

Kristopher Garibay, Eric Olson and Jonathon Salsbury of PPD® Laboratories GMP Lab discuss how the use of particle size distribution profiles by laser diffraction is a common analytical technique utilized across multiple industries.

American pharmaceutical review logo